Humotech launches clinical pilot with ēlizur
By HME News Staff
Updated 9:43 AM CDT, Wed October 29, 2025
PITTSBURGH, Pa. – Humotech, a Pittsburgh-based pioneer in wearable robotics and mobility innovation, has launched a clinical pilot with ēlizur, a leading orthotics and prosthetics (O&P) provider. Debuting this fall, the initiative will bring Humotech’s Caplex System into clinical practice, giving patients the ability to “test drive” prosthetic feet before prescription – an approach poised to redefine the future of prosthetic care, the company says. By combining ēlizur’s patient-centered expertise with Humotech’s advanced clinical decision support technology, the pilot will empower clinicians to make more informed, data-driven decisions and help patients achieve better outcomes faster, it says. “I believe this patient-centric technology will create a more efficient and appropriate prosthetic foot selection process for both the patient and the prosthetist,” said Brad Scott, director of Prosthetics & Orthotics at ēlizur. “Patients will spend less time in the clinic while being matched with the most biomechanically suitable foot. Meanwhile, practitioners will no longer have to juggle ordering and returning multiple feet from manufacturers. I also believe this technology will provide strong medical justification when obtaining a new foot for a patient transitioning from their preparatory prosthesis to their definitive one.”
Comments